| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
Indications
| Mesh Heading | Maximum Phase | Reference | |
|---|---|---|---|
| Schizophrenia | Phase 2 | ClinicalTrials | |
| Alzheimer Disease | Phase 2 | ClinicalTrials | |
| Cognitive Dysfunction; Schizophrenia | Phase 2 | ClinicalTrials |
CONTENTS